Mart van de Laar

1.5k total citations
21 papers, 624 citations indexed

About

Mart van de Laar is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Mart van de Laar has authored 21 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 6 papers in Hematology and 4 papers in Immunology. Recurrent topics in Mart van de Laar's work include Rheumatoid Arthritis Research and Therapies (14 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). Mart van de Laar is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). Mart van de Laar collaborates with scholars based in Netherlands, United States and France. Mart van de Laar's co-authors include Monique Hoekstra, C.J. Haagsma, Cees Neef, Johannes H. Proost, Désirée van der Heijde, Marco Matucci‐Cerinic, I. Logeart, Nicholas Bellamy, Claire Bombardier and Florence Tubach and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and BMC Musculoskeletal Disorders.

In The Last Decade

Mart van de Laar

19 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mart van de Laar Netherlands	13	385	152	82	77	69	21	624
Jesús Tornero Spain	14	369 1.0×	111 0.7×	176 2.1×	49 0.6×	66 1.0×	35	738
Savia de Souza United Kingdom	11	364 0.9×	138 0.9×	38 0.5×	37 0.5×	31 0.4×	23	626
Jesús Tornero Molina Spain	12	173 0.4×	78 0.5×	131 1.6×	46 0.6×	20 0.3×	34	438
Michele Hooper United States	12	200 0.5×	94 0.6×	58 0.7×	43 0.6×	31 0.4×	16	506
T. Uhlig Norway	11	536 1.4×	218 1.4×	52 0.6×	27 0.4×	33 0.5×	18	707
Regina M. Taylor‐Gjevre Canada	16	190 0.5×	71 0.5×	34 0.4×	72 0.9×	27 0.4×	42	728
Sally Youssef Egypt	13	294 0.8×	138 0.9×	75 0.9×	154 2.0×	12 0.2×	29	620
Mary Altz‐Smith United States	7	310 0.8×	109 0.7×	67 0.8×	40 0.5×	34 0.5×	8	518
Karel Ronday Netherlands	8	449 1.2×	304 2.0×	29 0.4×	21 0.3×	30 0.4×	15	630
Louise Pollard United Kingdom	10	487 1.3×	255 1.7×	56 0.7×	20 0.3×	32 0.5×	15	743

Countries citing papers authored by Mart van de Laar

Since Specialization

Citations

This map shows the geographic impact of Mart van de Laar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mart van de Laar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mart van de Laar more than expected).

Fields of papers citing papers by Mart van de Laar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mart van de Laar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mart van de Laar. The network helps show where Mart van de Laar may publish in the future.

Co-authorship network of co-authors of Mart van de Laar

This figure shows the co-authorship network connecting the top 25 collaborators of Mart van de Laar. A scholar is included among the top collaborators of Mart van de Laar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mart van de Laar. Mart van de Laar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Voshaar, Martijn A. H. Oude, et al.. (2025). Treat to Target in Gout Management: A Critical Reappraisal of Current Strategies. University of Twente Research Information. 3(1). 3–3.

Voshaar, Martijn A. H. Oude, Peter M. ten Klooster, Danyta I. Tedjo, et al.. (2024). PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs. RMD Open. 10(2). e004291–e004291. 5 indexed citations

Putrik, Polina, Jany Rademakers, Mart van de Laar, et al.. (2020). Addressing Health Literacy Needs in Rheumatology: Which Patient Health Literacy Profiles Need the Attention of Health Professionals?. Arthritis Care & Research. 73(1). 100–109. 31 indexed citations

Michaud, Kaleb, Janet Pope, Mart van de Laar, et al.. (2020). Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis. Arthritis Care & Research. 73(11). 1606–1616. 47 indexed citations

Putrik, Polina, Jany Rademakers, Mart van de Laar, et al.. (2019). SAT0558 IDENTIFYING HEATH LITERACY PROFILES OF RA AND SPA PATIENTS USING THE HEALTH LITERACY QUESTIONNAIRE. Annals of the Rheumatic Diseases. 78. 1371–1373.

Voshaar, Martijn A. H. Oude, et al.. (2019). OP0313 COST-EFFECTIVENESS OF A JAK1/JAK2-INHIBITOR VS. A BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG IN A TREAT-TO-TARGET STRATEGY FOR RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 78. 238–239. 2 indexed citations

Alten, Rieke, et al.. (2019). Physical and Emotional Burden of Rheumatoid Arthritis: Data from RA Matters, a Web-Based Survey of Patients and Healthcare Professionals. Rheumatology and Therapy. 6(4). 587–597. 12 indexed citations

Klooster, Peter M. ten, et al.. (2019). Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. Arthritis Research & Therapy. 21(1). 237–237. 15 indexed citations

Webers, Casper, Annelies Boonen, Yvonne van Eijk‐Hustings, et al.. (2019). Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net). RMD Open. 5(1). e000860–e000860. 19 indexed citations

10.

Taylor, Peter C., Mart van de Laar, Jeffrey R. Curtis, et al.. (2019). AB0449 PAIN REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB MONOTHERAPY WITH OR WITHOUT PAIN MEDICATION: A POST HOC ANALYSIS OF POOLED DATA FROM PHASE 2, PHASE 3 AND PHASE 3B/4 STUDIES. Annals of the Rheumatic Diseases. 78. 1687–1688. 1 indexed citations

11.

Laar, Mart van de, Janet Pope, Yvonne Lee, et al.. (2019). AB0287 BENEFITS OF PAIN RELIEF ON FATIGUE, FUNCTION, AND QUALITY OF LIFE WHEN JOINT INFLAMMATION IS CONTROLLED IN PATIENTS WITH RA. Annals of the Rheumatic Diseases. 78. 1601–1601. 2 indexed citations

12.

Ramiro, Sofía, Polina Putrik, Yvonne van Eijk‐Hustings, et al.. (2018). The eumusc.net standards of care for rheumatoid arthritis: importance and current implementation according to patients and healthcare providers in the Netherlands.. PubMed. 36(2). 275–283. 1 indexed citations

13.

Webers, Casper, Mart van de Laar, Jolanda J. Luime, et al.. (2018). Employment and the role of personal factors among patients with ankylosing spondylitis: a Dutch cross-sectional case-control study. RMD Open. 4(1). e000680–e000680. 15 indexed citations

14.

Voshaar, Martijn A. H. Oude, Marloes van Onna, Mart van de Laar, et al.. (2016). Development and Validation of a Short Form of the Social Role Participation Questionnaire in Patients with Ankylosing Spondylitis. The Journal of Rheumatology. 43(7). 1386–1392. 15 indexed citations

15.

Ramiro, Sofía, Robert Landewé, Maxime Dougados, et al.. (2016). The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis. The Journal of Rheumatology. 43(9). 1680–1686. 41 indexed citations

16.

Voshaar, Marieke, Johanna E Vriezekolk, Sandra van Dulmen, Bart J. F. van den Bemt, & Mart van de Laar. (2016). Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study. BMC Musculoskeletal Disorders. 17(1). 442–442. 28 indexed citations

17.

Bellamy, Nicholas, Marc C. Hochberg, Florence Tubach, et al.. (2015). Development of Multinational Definitions of Minimal Clinically Important Improvement and Patient Acceptable Symptomatic State in Osteoarthritis. Arthritis Care & Research. 67(7). 972–980. 85 indexed citations

18.

Pergolizzi, Joseph V., et al.. (2013). Tramadol/Paracetamol Fixed-Dose Combination for Chronic Pain Management in Family Practice: A Clinical Review. PubMed. 2013. 1–15. 8 indexed citations

19.

Laar, Mart van de, et al.. (2012). Pain Treatment in Arthritis-Related Pain: Beyond NSAIDs. The Open Rheumatology Journal. 6(1). 320–330. 112 indexed citations

20.

Dubbeldam, Rosemary, et al.. (2011). We should not forget the foot: relations between signs and symptoms, damage, and function in rheumatoid arthritis. Clinical Rheumatology. 30(11). 1475–1479. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact